News

Latest News | 29 January 2013

Does Advisory Committee Transparency Lead to Better Regulatory Decision Making?

0 Likes

The US Food and Drug Administration (FDA) often courts controversy with its decisions to approve or deny new therapies. In the wake of some high-profile scandals in the past decade, the agency has Read More...

---

Latest News | 12 October 2012

Auditors Hit EMA for Failing to Meet Conflict of Interest Standards

0 Likes

Auditors with the European Court of Auditors (ECA) have determined that the European Medicines Agency (EMA), despite its attempts to increase transparency and implement conflict-of-interest (COI) Read More...

---

Latest News | 1 October 2012

Bill Delaying Transparency Measures Passed Into Law

0 Likes

US legislators have delayed the implementation of legislation that would have required dozens of high-ranking officials at the US Food and Drug Administration and other federal agencies to disclose Read More...

---

Latest News | 19 September 2012

Top FDA Officials' Financial Records Could Soon be Made Publicly Available

0 Likes

Tens of thousands of high-level staff members at all federal agencies, including hundreds at the US Food and Drug Administration (FDA), will soon be required to publicly disclose their financial Read More...

---

Latest News | 19 June 2012

Group Nominates More Than 60 Scientists to Fill Advisory Committee Vacancies

0 Likes

Just how hard is it to find un-conflicted experts for the US Food and Drug Administration’s (FDA) Advisory Committees? The question is at the heart of a long-running skirmish between FDA, industry, Read More...

---

Latest News | 14 May 2012

European Parliament Still Dissatisfied With EMA's Conflict of Interest Policies

0 Likes

The European Parliament is still refusing to sign off on the European Medicines Agency’s (EMA) 2010 budget expenditures, the latest development in a long-running fight over the agency’s credibility, Read More...

---

Latest News | 14 May 2012

EMA's Rasi Moves to Streamline Conflict of Interest Policies at EMA

0 Likes

The European Medicines Agency (EMA) has released an updated procedure governing how the agency’s employees are investigated for any potential conflicts of interest (COI) relative to their duties Read More...

---

Latest News | 4 April 2012

EMA Tightens Conflict-of-Interest Policies

1 Likes

The European Medicines Agency (EMA) announced it will, effective immediately, be tightening its conflict-on-interest policies for scientific experts and members of advisory committees.The policy was Read More...

---

Latest News | 26 March 2012

EMA Strengthens Conflict of Interest Policies

0 Likes

The European Medicines Agency (EMA) announced Monday, 26 March its Management Board has endorsed a proposal from EMA Executive Director Guido Rasi to strengthen conflict of interest policies Read More...

---

Latest News | 5 March 2012

FDA Retreats From Earlier Advocacy of COI Rule Changes

0 Likes

US Food and Drug Administration (FDA) Commissioner Margaret Hamburg retreated from her earlier advocacy of changing conflict-of-interest (COI) rules at a House Appropriations Committee hearing 1 Read More...

---